Resource Centre > Research Gateway > DocuSign > Digitizing the Global Life Sciences Supply Chain:The Critical Role of Digital Transaction Management

Digitizing the Global Life Sciences Supply Chain:The Critical Role of Digital Transaction Management

DocuSign

Life science companies are experiencing a significant transformation in how they bring new products to market.
Organizations must adapt to changes in the marketplace, such as global product commercialization, specialized medicine, new regulations, new payment models, and new technology that are driving more product variety, smaller drug volumes, and shorter product life cycles.
To meet the needs of this new commercial model, life science companies must re-envision the global supply chain and evolve the tools they use to run their business. The supply chain that was designed for launching blockbuster products will not work in the future.
Today, the global supply chain relies on a manual, paper-based process centered on printing documents and sending them via overnight mail, fax, or e-mail with scanned attachments. This time-consuming and costly process is errorprone, tedious for customers and team members, and vulnerable to security and compliance risks.

Email this page
Published:  Apr 24, 2018
Length:  12
Type:  White Paper
Tags :